drugset / Trial / NCT00398281
Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer
Phase 3
Completed
450 enrolled
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
National Cancer Institute (NCI) · collab
RandomizedDouble-blindDiagnostic
Summary
RATIONALE: Diagnostic procedures, such as ultrasound-guided biopsy, may help find prostate cancer. Dutasteride may improve the ability of ultrasound-guided biopsy to find prostate cancer. It is not yet known whether dutasteride followed by ultrasound-guided biopsy is more effective than a placebo followed by ultrasound-guided biopsy in finding prostate cancer. PURPOSE: This randomized phase III trial is studying dutasteride and ultrasound-guided biopsy to see how well they find prostate cancer compared with a placebo and ultrasound-guided biopsy.
Timeline
- Start
- 2006-11
- Primary completion
- 2010-07
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutasteride | Small molecule | — | Oral |